ARTICLE | Translation in Brief
How Biognosys is mapping cell-wide drug-protein interactions
February 8, 2018 11:02 PM UTC
Biognosys is using a method developed by ETHZ researchers for the unbiased detection of molecular targets based on protein-metabolite interactions to study inter- and intra-patient variances in the proteome.
The protein services CRO will also offer the method to clients to help identify the proteins targeted by small molecule hits from phenotypic screens and to elucidate the molecules’ modes of action...